201 related articles for article (PubMed ID: 24401017)
21. A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.
Bellows BK; Dahal A; Jiao T; Biskupiak J
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):153-64. PubMed ID: 22509775
[TBL] [Abstract][Full Text] [Related]
22. Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine.
Zhao Y; Chen SY; Wu N; Fraser KA; Boulanger L
Pain Pract; 2011; 11(4):381-91. PubMed ID: 21199311
[TBL] [Abstract][Full Text] [Related]
23. Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care.
Kleinman NL; Sanchez RJ; Lynch WD; Cappelleri JC; Beren IA; Joshi AV
Pain Pract; 2011; 11(6):540-51. PubMed ID: 21392253
[TBL] [Abstract][Full Text] [Related]
24. Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.
Peng X; Sun P; Novick D; Andrews J; Sun S
J Pain Res; 2014; 7():37-46. PubMed ID: 24470771
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
Häuser W; Petzke F; Sommer C
J Pain; 2010 Jun; 11(6):505-21. PubMed ID: 20418173
[TBL] [Abstract][Full Text] [Related]
26. Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
Luciano JV; D'Amico F; Cerdà-Lafont M; Peñarrubia-María MT; Knapp M; Cuesta-Vargas AI; Serrano-Blanco A; García-Campayo J
Arthritis Res Ther; 2014 Oct; 16(5):451. PubMed ID: 25270426
[TBL] [Abstract][Full Text] [Related]
27. Impact of a prior authorization for pregabalin on health plan drug expenditures.
Bazalo G; Weiss RC; Joshi AV
Am J Manag Care; 2010 May; 16(5 Suppl):S154-9. PubMed ID: 20586524
[TBL] [Abstract][Full Text] [Related]
28. Identification of patients with painful diabetic peripheral neuropathy who have a favorable cost profile with pregabalin treatment.
Udall M; Mardekian J; Cabrera J
Pain Pract; 2013 Jul; 13(6):476-84. PubMed ID: 23150918
[TBL] [Abstract][Full Text] [Related]
29. Predictors of pain medication selection among patients diagnosed with fibromyalgia.
Boulanger L; Wu N; Chen SY; Nagar S; Fraser K; Bernauer MJ; Zhao Z; Zhao Y
Pain Pract; 2012 Apr; 12(4):266-75. PubMed ID: 21899718
[TBL] [Abstract][Full Text] [Related]
30. Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia.
Ellis JJ; Sadosky AB; Ten Eyck LL; Cappelleri JC; Brown CR; Suehs BT; Parsons B
Clinicoecon Outcomes Res; 2014; 6():389-99. PubMed ID: 25339847
[TBL] [Abstract][Full Text] [Related]
31. Fibromyalgia coverage uneven despite recent drug approvals.
Sipkoff M
Manag Care; 2008 Dec; 17(12):9-10. PubMed ID: 19127758
[No Abstract] [Full Text] [Related]
32. Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico.
Arreola Ornelas H; Rosado Buzzo A; García L; Dorantes Aguilar J; Contreras Hernández I; Mould Quevedo JF
Reumatol Clin; 2012; 8(3):120-7. PubMed ID: 22386298
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalin.
Kim SC; Landon JE; Solomon DH
Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1813-9. PubMed ID: 23861291
[TBL] [Abstract][Full Text] [Related]
34. Estimating the economic benefits of positive shifts in fibromyalgia severity: an exploratory analysis based on modeling of clinical trial data of pregabalin.
Cappelleri JC; Bushmakin AG; Zlateva G; Chandran A
J Med Econ; 2013; 16(1):55-61. PubMed ID: 22954060
[TBL] [Abstract][Full Text] [Related]
35. Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain.
Sun P; Zhao Y; Zhao Z; Bernauer M; Watson P
Pain Pract; 2012 Nov; 12(8):641-8. PubMed ID: 22335435
[TBL] [Abstract][Full Text] [Related]
36. Pregabalin (Lyrica) for fibromyalgia.
Med Lett Drugs Ther; 2007 Sep; 49(1270):77-8. PubMed ID: 17878888
[No Abstract] [Full Text] [Related]
37. Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy.
Udall M; Harnett J; Mardekian J
J Med Econ; 2012; 15(2):361-70. PubMed ID: 22181052
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.
García-Campayo J; Serrano-Blanco A; Rodero B; Magallón R; Alda M; Andrés E; Luciano JV; del Hoyo YL
Trials; 2009 Apr; 10():24. PubMed ID: 19389246
[TBL] [Abstract][Full Text] [Related]
39. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
Roth T; Lankford DA; Bhadra P; Whalen E; Resnick EM
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
[TBL] [Abstract][Full Text] [Related]
40. Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia.
Angeletti C; Guetti C; Piroli A; Angeletti PM; Paladini A; Ciccozzi A; Marinangeli F; Varrassi G
Pain Pract; 2013 Nov; 13(8):657-62. PubMed ID: 23126475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
